MedTrace Logo

Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population

NCT01828060 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2014-09-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the timing and magnitude of improvements to red blood cell health associated with consumption of Jobelyn™.

Conditions

Interventions

DIETARY_SUPPLEMENT

Jobelyn™

Sorghum bicolor leaf sheath extract

DIETARY_SUPPLEMENT

Placebo

Placebo capsules

Sponsors & Collaborators

  • Natural Immune Systems Inc

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01828060 on ClinicalTrials.gov